Lunit
Lunit is a pioneering company in the field of AI-powered cancer diagnostics and therapeutics. Their mission is to conquer cancer through AI, developing innovative solutions for precision oncology. Lunit's product portfolio includes Lunit INSIGHT CXR for AI-powered chest X-ray analysis, Lunit INSIGHT MMG for AI-based mammogram interpretation assistance, Lunit SCOPE IO for AI-powered immune phenotyping biomarkers, and Lunit SCOPE PD-L1 for AI-assisted PD-L1 scoring in cancer immunotherapy. The company's AI solutions extend beyond clinical applications to support drug discovery and development processes. Lunit's technology aims to enhance the accuracy and efficiency of cancer screening, diagnosis, and treatment response prediction, ultimately improving patient outcomes in oncology.
Key Offerings
- Lunit INSIGHT CXR - AI-powered chest X-ray analysis solution
- Lunit INSIGHT MMG - AI-based mammogram interpretation assistance
- Lunit SCOPE IO - AI-powered biomarker for immune phenotyping
- Lunit SCOPE PD-L1 - AI tool for PD-L1 scoring in cancer immunotherapy
- AI solutions for drug discovery and development
Add a company to the AI for Healthcare Hub
Add your company to the directory to showcase your AI solutions and services.
We will review your company and add it to the list.
Stay Updated on AI for Healthcare
Subscribe to our newsletter for the latest updates on artificial intelligence in healthcare.
We respect your privacy. Your information is safe with us.